Speed
43 days to first decision for all manuscripts
63 days to first decision for reviewed manuscripts only
152 days from submission to acceptance
18 days from acceptance to publication
Citation Impact
3.054 - 2-year Impact Factor
3.497 - 5-year Impact Factor
1.315 - Source Normalized Impact per Paper (SNIP)
1.051 - SCImago Journal Rank (SJR)
Usage
917,107 Downloads (2021)
517 Altmetric mentions
Articles
Page 1 of 64
-
Citation: Pediatric Rheumatology 2022 20:36
-
The use of ECMO in pediatric granulomatosis with polyangiitis
Granulomatosis with polyangiitis (GPA) vasculitis with pulmonary-renal syndrome rarely presents in children and is associated with high mortality rates.
Citation: Pediatric Rheumatology 2022 20:35 -
Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes
Childhood leukemia with musculoskeletal (MSK) involvement mimics various conditions, which consequently leads to diagnostic delays. The clinical implication of MSK involvement in this disease on survival outco...
Citation: Pediatric Rheumatology 2022 20:34 -
Correction: the characteristics of video capsule endoscopy in pediatric Henoch–Schönlein purpura with gastrointestinal symptoms
An amendment to this paper has been published and can be accessed via the original article.
Citation: Pediatric Rheumatology 2022 20:33 -
Restricted upper airway dimensions in patients with dentofacial deformity from juvenile idiopathic arthritis
This retrospective, cross-sectional study aimed to assess the pharyngeal airway dimensions of patients with juvenile idiopathic arthritis (JIA) and moderate/severe JIA-related dentofacial deformity (mandibular...
Citation: Pediatric Rheumatology 2022 20:32 -
In a large Juvenile Idiopathic Arthritis (JIA) cohort, concomitant celiac disease is associated with family history of autoimmunity and a more severe JIA course: a retrospective study
A higher prevalence of celiac disease (CD) has been reported in patients with juvenile idiopathic arthritis (JIA) compared to the general population. Factors related to the increased risk of co-occurrence and ...
Citation: Pediatric Rheumatology 2022 20:31 -
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis
We present two cases of Nodular Regenerative Hyperplasia (NRH) associated with Juvenile Dermatomyositis (JDM).
Citation: Pediatric Rheumatology 2022 20:30 -
Pseudotumor cerebri syndrome in children with systemic lupus erythematosus: case series and review
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease that typically affects multiple organs and can lead to potentially fatal complications. Central nervous system (CNS) involvement ...
Citation: Pediatric Rheumatology 2022 20:29 -
Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes
Environmental exposures have been associated with the juvenile idiopathic inflammatory myopathies (JIIM). We undertook a questionnaire-based study to evaluate patient-reported exposures as possible risk factor...
Citation: Pediatric Rheumatology 2022 20:28 -
Transition readiness in adolescents and young adults with chronic rheumatic disease in Oman: today’s needs and future challenges
In Oman, the ““transition” of health care of adolescents to adult care occurs at a young age, like many other GCC countries for cultural reasons. In order to address this concern, this study was conducted to d...
Citation: Pediatric Rheumatology 2022 20:27 -
Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients
The plasticity of T helper-17 (Th17) and regulatory T (Treg) cells may be a clue to pathogenesis of Juvenile Idiopathic Arthritis (JIA). It is still unclear, whether targeted suppression of Interleukin (IL)-17...
Citation: Pediatric Rheumatology 2022 20:26 -
Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
Pharmacological treatment is a cornerstone of care for children with juvenile idiopathic arthritis (JIA). The objective of this study is to evaluate prescription patterns of conventional and biologic disease m...
Citation: Pediatric Rheumatology 2022 20:25 -
Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report
Singleton-Merten syndrome 1 (SGMRT1) is a rare type I interferonopathy caused by heterozygous mutations in the IFIH1 gene. IFIH1 encodes the pattern recognition receptor MDA5 which senses viral dsRNA and activate...
Citation: Pediatric Rheumatology 2022 20:24 -
In pediatric rheumatologic disease, methotrexate leads to mildly changed bloodwork on the second day after administration
Citation: Pediatric Rheumatology 2022 20:23 -
Challenging the silent temporomandibular joint paradigm in children with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2022 20:22 -
Feasibility of the wingate anaerobic exercise test as a clinical measure in patients with juvenile dermatomyositis
Core sets, while widely adopted for clinical assessment in juvenile dermatomyositis (JDM), have some drawbacks – they are time consuming, were developed primarily for research, and require an experienced multi...
Citation: Pediatric Rheumatology 2022 20:21 -
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up
Our aims were to clinically and epidemiologically characterize rheumatic fever (RF) in the current era in Israel. Although there has been a steady decline in the incidence of RF in the western world, evidence ...
Citation: Pediatric Rheumatology 2022 20:20 -
Correction to: Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares
Citation: Pediatric Rheumatology 2022 20:19 -
Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis
Social determinants of health (SDH) greatly influence outcomes during the first year of treatment in rheumatoid arthritis, a disease similar to polyarticular juvenile idiopathic arthritis (pJIA). We investigat...
Citation: Pediatric Rheumatology 2022 20:18 -
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series
Pediatric antiphospholipid syndrome (APS) is a thromboinflammatory disease characterized by the presence of circulating antiphospholipid antibodies and either thrombotic events or pregnancy morbidity. The obje...
Citation: Pediatric Rheumatology 2022 20:17 -
Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review
Macrophage activation syndrome (MAS) is a severe and under-recognized complication of rheumatologic diseases. We describe a patient who presented with rapidly progressive, refractory MAS found to have anti-MD...
Citation: Pediatric Rheumatology 2022 20:16 -
Outcomes of transitional care programs on adolescent chronic inflammatory systemic diseases: systematic review and meta-analyses
Patients with juvenile chronic inflammatory systemic diseases (jCID) are vulnerable to many circumstances when transitioning to adult-centered healthcare; this increases the burden of disease and worsen their ...
Citation: Pediatric Rheumatology 2022 20:15 -
Exploring the intersection of adverse childhood experiences, pediatric chronic pain, and rheumatic disease
While the general relationship between ACEs and the development of chronic pain has become increasingly clear, how ACEs may shape a child’s clinical presentation with regards to chronic pain has yet to be full...
Citation: Pediatric Rheumatology 2022 20:14 -
Primary antiphospholipid syndrome in pediatrics: beyond thrombosis. Report of 32 cases and review of the evidence
Describe the frequency of thrombotic and non-thrombotic clinical manifestations, laboratory, treatment and prognosis in patients with pediatric primary antiphospholipid syndrome.
Citation: Pediatric Rheumatology 2022 20:13 -
Serine, N-acetylaspartate differentiate adolescents with juvenile idiopathic arthritis compared with healthy controls: a metabolomics cross-sectional study
In comparison with the general population, adolescents with juvenile idiopathic arthritis (JIA) are at higher risk for morbidity and mortality. However, limited evidence is available about this condition’s und...
Citation: Pediatric Rheumatology 2022 20:12 -
Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud’s phenomenon
Nailfold capillary microscopy (NCM) is a cornerstone in the diagnosis of Systemic Sclerosis (SSc) in adulthood. Although Raynaud’s phenomenon (RP) is very common in childhood, studies on diagnostic methods to ...
Citation: Pediatric Rheumatology 2022 20:11 -
Translating research into practice—implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreat
The translation of research findings into clinical practice is challenging, especially fields like in pediatric rheumatology, where the evidence base is limited, there are few clinical trials, and the conditio...
Citation: Pediatric Rheumatology 2022 20:10 -
NLRP12-associated systemic autoinflammatory diseases in children
Systemic autoinflammatory diseases (SAIDs) are a group of monogenic diseases characterized by disordered innate immunity, which causes excessive activation of inflammatory pathways. Nucleotide-binding leucine-...
Citation: Pediatric Rheumatology 2022 20:9 -
Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA
An association of different autoimmune diseases is suspected. In juvenile idiopathic arthritis (JIA), only few and partially conflicting data on the co-existence of other autoimmune disorders are available. Th...
Citation: Pediatric Rheumatology 2022 20:8 -
Catch-up growth of infants born to mothers with autoimmune rheumatic disorders
In women with autoimmune rheumatic disorders (ARD), pregnancy complications or postpartum events are more frequent compared to the general population. Transplacental autoantibodies or cytokines influence vario...
Citation: Pediatric Rheumatology 2022 20:7 -
Joint involvement, disease activity and quality of life in pediatric Crohn’s disease – a cross-sectional study
Few published data describe how joint involvement, the most prevalent extraintestinal manifestation, affects quality of life (QoL) of children with Crohn’s disease (CD). Arthritis and arthralgia rates in pedia...
Citation: Pediatric Rheumatology 2022 20:6 -
The efficacy and safety of intra-articular injection of triamcinolone acetonide versus triamcinolone hexacetonide for treatment of juvenile idiopathic arthritis
Juvenile idiopathic arthritis (JIA) is the most common childhood rheumatic disease. Intra-articular corticosteroids joint injection (IAJI), with triamcinolone hexacetonide (TH) or triamcinolone acetonide (TA),...
Citation: Pediatric Rheumatology 2022 20:5 -
Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus
Growth impairment is the most common complication in patients with childhood-onset systemic lupus erythematosus (cSLE). There are limited data on risk factors affecting growth development in Asian patients wit...
Citation: Pediatric Rheumatology 2022 20:4 -
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis
Juvenile idiopathic arthritis (JIA) is a cluster of autoimmune rheumatic diseases occurring in children 16 years of age or less. While it is well-known that pain may be experienced during inflammatory and non-...
Citation: Pediatric Rheumatology 2022 20:3 -
Abstracts from the ISSAID 2021 Periodic Congress
Citation: Pediatric Rheumatology 2022 20(Suppl 1):2 -
Clinical characteristics and outcomes of chronic nonbacterial osteomyelitis in children: a multicenter case series
The aim of this study was to evaluate demographic, clinical, laboratory, imaging, histopathology characteristics, and treatment responses of children with Chronic nonbacterial osteomyelitis (CNO).
Citation: Pediatric Rheumatology 2022 20:1 -
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study
This study aimed to perform an immunoprofiling of systemic juvenile idiopathic arthritis (sJIA) in order to define biomarkers of clinical use as well as reveal new immune mechanisms.
Citation: Pediatric Rheumatology 2021 19:173 -
A descriptive study on multisystem inflammatory syndrome in children in a single center in West Michigan
Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare hyperinflammatory condition that occurs following SARS-CoV-2 infection. There is a paucity of research describing risk factors, optimal managemen...
Citation: Pediatric Rheumatology 2021 19:172 -
Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis
Juvenile idiopathic arthritis (JIA) is common and difficult to treat. Cannabidiol (CBD) is now widely available, but no studies to date have investigated the use of CBD for JIA.
Citation: Pediatric Rheumatology 2021 19:171 -
Evaluation of pediatric rheumatology telehealth satisfaction during the COVID-19 pandemic
During the Coronavirus disease 2019 pandemic, ambulatory pediatric rheumatology healthcare rapidly transformed to a mainly telehealth model. However, pediatric patient and caregiver satisfaction with broadly d...
Citation: Pediatric Rheumatology 2021 19:170 -
Best practices for recruitment of adolescents for biobanking and precision health research: a retrospective analysis comparing juvenile idiopathic arthritis cases with healthy controls
Precision health in adolescents relies on the successful collection of data and biospecimens from an adequately sized sample of cases and comparison group(s), often healthy controls, to answer the research que...
Citation: Pediatric Rheumatology 2021 19:169 -
A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report
Childhood Polyarteritis nodosa (PAN) is a systemic vasculitis with necrotizing inflammation of medium- and small-sized arteries. Disease evolution may be severe and refractory to standard treatment including p...
Citation: Pediatric Rheumatology 2021 19:168 -
Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor
The objective of this work was to describe magnetic resonance imaging (MRI) changes over time in inflammatory and structural lesions at the sacroiliac joint (SIJ) in children with spondyloarthritis (SpA) expos...
Citation: Pediatric Rheumatology 2021 19:167 -
Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East
Juvenile Idiopathic Arthritis (JIA) is a group of chronic heterogenous disorders that manifests as joint inflammation in patients aged <16 years. Globally, approximately 3 million children and young adults are...
Citation: Pediatric Rheumatology 2021 19:166 -
Correction to: Evaluating the performance of ACR, SLICC and EULAR/ACR classification criteria in childhood onset systemic lupus erythematosus
Citation: Pediatric Rheumatology 2021 19:165 -
A novel transition clinic structure for adolescent and young adult patients with childhood onset rheumatic disease improves transition outcomes
The transition of health care from Pediatric to Adult providers for adolescents and young adults with chronic disease is associated with poor outcomes. Despite the importance of this transition, over 80% of th...
Citation: Pediatric Rheumatology 2021 19:164 -
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication
Flares of juvenile idiopathic arthritis (JIA) have been described in the context of various infections. Flares of rheumatic diseases in adults have been described following infection with SARS-CoV-2 in several...
Citation: Pediatric Rheumatology 2021 19:163 -
Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases
This study aimed to assess the baseline characteristics and clinical outcomes of coronavirus disease 2019 (COVID-19) in pediatric patients with rheumatic and musculoskeletal diseases (RMD) and identify the ris...
Citation: Pediatric Rheumatology 2021 19:162 -
Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report
Mevalonate kinase deficiency (MKD) is a rare autoinflammatory condition caused by biallelic loss-of-function (LOF) mutations in mevalonate kinase (MVK) gene encoding the enzyme mevalonate kinase. Patients with MK...
Citation: Pediatric Rheumatology 2021 19:161 -
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients
Blau syndrome (BS), a rare, autosomal-dominant autoinflammatory syndrome, is characterized by a clinical triad of granulomatous recurrent uveitis, dermatitis, and symmetric arthritis and associated with mutati...
Citation: Pediatric Rheumatology 2021 19:160